Increased androgenicity as assessed by increased testosterone and decreased SHBG is strongly associated with an unfavorable body fat distribution and increased glucose and insulin concentrations and insulin resistance in both preand postmenopausal women. However, the temporal direction of the association between androgens and insulin is uncertain. In men, the association between SHBG and insulin levels is much weaker and is probably inverse.
Introduction
Increased obesity (body mass index, BMI) and an adverse body fat distribution (ie, high waist-to-hip ratio, WHR) are associated with decreased levels of sex hormone binding (SHBG) in both men and women. A summary of cross-sectional associations of SHBG with obesity, body fat distribution, glucose, and insulin concentrations is shown in Table 1 . 1 ± 10 Since the effects of sex hormones on concentrations of glucose and insulin may differ on insulin resistance in normal women, we will discuss results separately in men and women.
Intervention studies
In animals, the effects of testosterone on insulin sensitivity may differ in males and females. Female rats treated with testosterone have decreases in both insulin sensitivity and the proportion of red muscle ®bers. 11 The situation in male rats is more compIicated. 12 Castrated male rats have increased insulin resistance, which is improved by low-dose (replacement) testosterone administration. Treatment with high-dose testosterone, however, worsens insulin resistance.
There are few data available on the effect of sex hormones on body fat distribution in humans. Ma Êrin and Holma Êng 13 have recently shown that testosterone administration in middle-aged abdominally obese men decreased visceral fat and improves insulin sensitivity.
Women
Kissebah et al 14 showed that regional body fat distribution was associated with glucose intolerance and hyperinsulinemia in premenopausal women. Further work by this group showed that upper body adiposity was associated with increased free testosterone and decreased SHBG. 1 SHBG is thought to be an indirect measure of androgenicity with its concentrations mainly (although not exclusively) determined by the level of free estrogen and androgens; 15 increased glucose and insulin concentrations were associated with increased free testosterone and decreased SHBG in nondiabetic subjects in the San Antonio Heart Study. 3 Upper body adiposity has also been associated with increased free testosterone and decreased SHBG.
1,2 While overall adiposity is associated with increased pancreatic secretion of insulin, 16 increased upper body adiposity is associated with decreased hepatic clearance of insulin. In addition, hepatic clearance of insulin shows a strong positive correlation with concentrations of SHBG. 17 Women with polycystic ovary syndrome (PCOS), who have increased levels of free testosterone, have increased insulin and glucose concentrations. 18, 19 Relatively few studies have been done on whether alterations in androgen levels predict metabolic disease. Two studies have shown that low levels of SHBG predict the incidence of NIDDM in women. 20, 21 These associations were not completely explained by differences in baseline insulin concentrations between converters and nonconverters to diabetes.
Men
In contrast to women, increased androgen concentrations do not seem to be associated with increased cardiovascular risk factors (increased triglyceride and insulin concentrations and decreased high density lipoprotein cholesterol levels). Several studies have suggested an inverse association between total testosterone and insulin concentrations. 10,22 ± 24 In one study, free testosterone was inversely associated with insulin concentrations. 10 While low SHBG was not a signi®-cant predictor of the development of type 2 diabetes in a small study of men, 21 both low SHBG and testosterone predicted the development of type 2 diabetes in a much larger group of men in the Multiple Risk Factor Intervention Trial. 25 Total testosterone concentrations are also lower in men with type 2 diabetes than in normoglycemic men. 26, 27 Only a few studies have examined the association of sex hormones with direct measures of insulin resistance such as the hyperinsulinemic euglycemic clamp. Birkeland et al 28 showed a strong correlation between insulin sensitivity and SHBG (r 0.74, P`0.001) and moderate correlations between insulin sensitivity and total testosterone (r 0.43, P`0.05) and waist-to-hip ratio (r À0.42, P`0.01) in 23 men with type 2 diabetes. These authors did not show a signi®cant association between insulin sensitivity and free testosterone (r À0.06), free estradiol (r À0.03) or BMI (r À0.39). The authors also showed that the association between SHBG and insulin sensitivity remained statistically signi®cant after adjustment for obesity and body fat distribution. In contrast, Haffner et al 29 have used indirect calorimetry combined with the euglycemic clamp to assess oxidative and nonoxidative glucose metabolism in 87 normoglycemic men. They showed a strong relationship between total and non-oxidative glucose disposal with SHBG (r 0.37 and r 0.32, respectively, both P`0.001).
Conclusion
In both pre-and postmenopausal women, increased androgenicity as assessed by increased testosterone and decreased SHBG is strongly associated with an unfavorable body fat distribution and increased glucose and insulin concentrations and insulin resistance. However, the temporal direction of the association between androgens and insulin is uncertain. In men, the association between SHBG and insulin levels is much weaker and is probably inverse. 
